Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |